Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bachtler, Barbara (1) Bader, Michael Prof. Dr. (20) Bähring, Sylvia Dr. (2) Birchmeier, Walter Prof. Dr. (7) Birchmeier-Kohler, Carmen Prof. Dr. (9) Blankenstein, Thomas Prof. Dr. (8) Falcke, Martin Prof. Dr. (4) Fielitz, Jens Dr. (1) Gerhardt, Holger Prof. Dr. (6) Gotthardt, Michael Prof. Dr. (4) Heinemann, Udo Prof. Dr. (3) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janz, Martin Dr. (1) Jentsch, Thomas Prof. Dr. (14) Kammertöns, Thomas Dr. (3) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (8) Kettritz, Ralph Prof. Dr. (5) Klußmann, Enno PD Dr. (1) Lee, Young-Ae Prof. Dr. (5) Leutz, Achim Prof. Dr. (1) Lewin, Gary Prof. Dr. (3) Luft, Friedrich Prof. Dr. (52) Mathas, Stephan Dr. (1) Morano, Ingo Prof. Dr. (5) Müller, Dominik Prof. Dr. (6) Niendorf, Thoralf Prof. Dr. (1) Ohler, Uwe Prof. Dr. (3) Pezzutto, Antonio Prof. Dr. (3) Pischon, Tobias Prof. Dr. (2) Rahn, Hans-Peter Dr. (1) Rajewsky, Nikolaus Prof. Dr. (2) Rehm, Armin Dr. (1) Saar, Kathrin Dr. (1) Sander, Maike Prof. Dr. (2) Scheidereit, Claus Prof. Dr. (6) Schlag, Peter M. Prof. Dr. (8) Schulz-Menger, Jeanette Prof. Dr. (5) Sporbert, Anje Dr. (2) Stein, Ulrike Prof. Dr. (8) von Kries, Jens Peter Dr. (1) Waiczies, Sonia PD Dr. (1) Wallukat, Gerd Dr. (2) Walther, Wolfgang Prof. Dr. (7) Wanker, Erich Prof. Dr. (5) Willimsky, Gerald Dr. (3) Willnow, Thomas Prof. Dr. (4) Wolf, Jana Prof. Dr. (2) (-) Dechend, Ralf Priv. Doz. (6) 1994 (3) 1995 (2) 1996 (2) 1997 (4) 1999 (3) (-) 2000 (6) 2001 (7) 2002 (9) 2003 (5) 2005 (9) 2006 (1) 2007 (11) 2008 (18) 2009 (14) 2010 (9) 2011 (11) 2012 (17) 2013 (17) 2014 (18) 2015 (15) 2016 (19) 2017 (16) 2018 (13) 2019 (17) 2020 (20) 2021 (14) 2022 (12) 2023 (15) 2024 (5) AG Müller/Dechend (ECRC) (5) Hypertension-caused End-Organ Damage (5) Hypertension-Mediated End-Organ Damage (5) 6 Results: Active Filter: Dechend, Ralf Priv. Doz.2000 Sort: Result score Newest to oldest Oldest to newest May 23, 2000 / Circulation AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor R. Dechend V. Homuth G. Wallukat J. Kreuzer J.K. Park J. Theuer A. Juepner D.C. Gulba N. Mackman H. Haller F.C. Luft July 01, 2000 / Am J Pathol Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy D.N. Mueller E.M.A. Mervaala R. Dechend A. Fiebeler J.K. Park F. Schmidt J. Theuer V. Breu N. Mackman T. Luther W. Schneider D. Gulba D. Ganten H. Haller F.C. Luft August 01, 2000 / Hypertension Effect of Bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage D.N. Muller E.M.A. Mervaala F. Schmidt J.K. Park R. Dechend E. Genersch V. Breu B.M. Loeffler D. Ganten W. Schneider H. Haller F.C. Luft January 01, 2000 / Hypertension NF-kappaB Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats D.N. Muller R. Dechend E.M.A. Mervaala J.K. Park F. Schmidt A. Fiebeler J. Theuer V. Breu D. Ganten H. Haller F.C. Luft January 01, 2000 / Hypertension Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes E. Mervaala D.N. Mueller J.K. Park R. Dechend F. Schmidt A. Fiebeler M. Bieringer V. Breu D. Ganten H. Haller F.C. Luft October 01, 2000 / Kidney Int Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects J.K. Park D.N. Mueller E.M.A. Mervaala R. Dechend A. Fiebeler F. Schmidt M. Bieringer O. Schaefer C. Lindschau W. Schneider D. Ganten F.C. Luft H. Haller
May 23, 2000 / Circulation AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor R. Dechend V. Homuth G. Wallukat J. Kreuzer J.K. Park J. Theuer A. Juepner D.C. Gulba N. Mackman H. Haller F.C. Luft
July 01, 2000 / Am J Pathol Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy D.N. Mueller E.M.A. Mervaala R. Dechend A. Fiebeler J.K. Park F. Schmidt J. Theuer V. Breu N. Mackman T. Luther W. Schneider D. Gulba D. Ganten H. Haller F.C. Luft
August 01, 2000 / Hypertension Effect of Bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage D.N. Muller E.M.A. Mervaala F. Schmidt J.K. Park R. Dechend E. Genersch V. Breu B.M. Loeffler D. Ganten W. Schneider H. Haller F.C. Luft
January 01, 2000 / Hypertension NF-kappaB Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats D.N. Muller R. Dechend E.M.A. Mervaala J.K. Park F. Schmidt A. Fiebeler J. Theuer V. Breu D. Ganten H. Haller F.C. Luft
January 01, 2000 / Hypertension Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes E. Mervaala D.N. Mueller J.K. Park R. Dechend F. Schmidt A. Fiebeler M. Bieringer V. Breu D. Ganten H. Haller F.C. Luft
October 01, 2000 / Kidney Int Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects J.K. Park D.N. Mueller E.M.A. Mervaala R. Dechend A. Fiebeler F. Schmidt M. Bieringer O. Schaefer C. Lindschau W. Schneider D. Ganten F.C. Luft H. Haller